Rigel Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $755.88 million, with shareholders equity totaling $445.11 million.
The company employs approximately 169 people and operates in the Services sector, within the Commercial Services industry.
Over the past 12 months, Rigel Pharmaceuticals Inc. reported $288.21 million in revenue, generating net income of $307.19 million.
Key financial metrics include a P/E ratio of 2.46, a price-to-book (P/B) ratio of 1.70, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker RIGL.